VERICEL CORPORATION Proceeds from Long-Term Debt Issued
VERICEL CORPORATION (VCEL) reported Proceeds from Long-Term Debt Issued of $751.00 thousand for the 300-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2014-05-15
- VERICEL CORPORATION proceeds from issuance of long-term debt for the quarter ending 2014-03-31 was $0.00.
- VERICEL CORPORATION proceeds from issuance of long-term debt for the quarter ending 2013-12-31 was $0.00.
- VERICEL CORPORATION proceeds from issuance of long-term debt for the quarter ending 2013-09-30 was $0.00.
- VERICEL CORPORATION proceeds from issuance of long-term debt for the quarter ending 2013-06-30 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 267 month | Proceeds from Issuance of Long-term Debt 270 month | Proceeds from Issuance of Long-term Debt 273 month | Proceeds from Issuance of Long-term Debt 276 month | Proceeds from Issuance of Long-term Debt 279 month | Proceeds from Issuance of Long-term Debt 282 month | Proceeds from Issuance of Long-term Debt 285 month | Proceeds from Issuance of Long-term Debt 288 month | Proceeds from Issuance of Long-term Debt 291 month | Proceeds from Issuance of Long-term Debt 294 month | Proceeds from Issuance of Long-term Debt 297 month | Proceeds from Issuance of Long-term Debt 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-Q 300 month − 10-K 297 month · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $751.00K 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 297 month − 10-Q 294 month · filed 2014-03-13 | $0.00 derived: sum of 2 quarters · filed 2014-03-13 | $0.00 derived: sum of 3 quarters · filed 2014-03-13 | $0.00 derived: sum of 4 quarters · filed 2014-03-13 | $751.00K 10-K · filed 2014-03-13 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 294 month − 10-Q 291 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2013-11-12 | $0.00 derived: sum of 4 quarters · filed 2013-11-12 | $751.00K 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 291 month − 10-Q 288 month · filed 2013-08-07 | $0.00 derived: sum of 2 quarters · filed 2013-08-07 | $0.00 derived: sum of 3 quarters · filed 2013-08-07 | $0.00 derived: sum of 4 quarters · filed 2013-08-07 | $751.00K 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 288 month − 10-K 285 month · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $0.00 derived: sum of 3 quarters · filed 2013-05-08 | $0.00 derived: sum of 4 quarters · filed 2013-05-08 | $751.00K 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 285 month − 10-Q 282 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $751.00K 10-K · filed 2013-03-18 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 282 month − 10-Q 279 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $751.00K 10-Q · filed 2012-11-08 | |||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 279 month − 10-Q 276 month · filed 2012-08-07 | $751.00K 10-Q · filed 2012-08-07 | ||||||||||||||
| 2012-03-31 | $751.00K 10-Q · filed 2012-05-10 | |||||||||||||||
| 2011-12-31 | $751.00K 10-K · filed 2012-03-15 | |||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 270 month − 10-Q 267 month · filed 2011-11-08 | $751.00K 10-Q · filed 2011-11-08 | ||||||||||||||
| 2011-06-30 | $751.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |